Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7361)
All Articles published online
|
Publishing Process of This Article
|
Jan 27, 2022 (publication date) through Oct 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Devi J, Raees A, Butt AS. Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible? World J Hepatol 2022; 14(1): 158-167 [PMID: 35126845 DOI: 10.4254/wjh.v14.i1.158] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i1/158.htm |
| Number | Citing Articles |
| 1 |
Maria Hernandez-Tejero, Samhita Ravi, Jaideep Behari, Gavin E. Arteel, Juan Pablo Arab, Ramon Bataller. High Variability on Alcohol Intake Threshold in Articles Using the MAFLD Acronym. Gastro Hep Advances 2024; 3(1): 96 doi: 10.1016/j.gastha.2023.08.016
|
| 2 |
Xue Wang, Jinlong You, Jing Tang, Xiuqian Li, Rui Wang, Yuanyuan Li, Chun Yin, Yana Bai, Minzhen Wang, Shan Zheng. Is MAFLD better than NAFLD in predicting the risk of major cardiovascular diseases? Evidence from a 7-year prospective cohort study. Nutrition, Metabolism and Cardiovascular Diseases 2025; 35(3): 103799 doi: 10.1016/j.numecd.2024.103799
|
| 3 |
Ornella Rotolo, Caterina Bonfiglio, Rosa Reddavide, Anna Maria Cisternino, Rosa Inguaggiato, Gianluigi Giannelli. The Effect of a Four-Month Low-Carbohydrate Diet on Visceral Adipose Tissue in Obese Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Nutrients 2025; 17(17): 2905 doi: 10.3390/nu17172905
|
| 4 |
Arkiath Veettil Raveendran. Type 2 diabetes mellitus: Isn’t it time to update the terminology?. World Journal of Diabetes 2025; 16(9): 107517 doi: 10.4239/wjd.v16.i9.107517
|
| 5 |
D. Yu. Venidiktova, A. V. Borsukov. Instrumental features of the differential diagnosis of metabolically associated and non-alcoholic fatty liver diseases. The Siberian Journal of Clinical and Experimental Medicine 2023; 38(2): 209 doi: 10.29001/2073-8552-2023-38-2-209-217
|
| 6 |
Seiji Nomura, Lixiang Wang, Nao Hasuzawa, Ayako Nagayama, Sawako Moriyama, Kenji Ashida, Yoshinori Moriyama, Masatoshi Nomura, Ken Yamamoto. Imeglimin attenuates liver fibrosis by inhibiting vesicular ATP release from hepatic stellate cells. FEBS Letters 2025; doi: 10.1002/1873-3468.70166
|
| 7 |
Francesca Lanzaro, Stefano Guarino, Elisabetta D'Addio, Alessandra Salvatori, Josè Alberto D'Anna, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa. Metabolic-associated fatty liver disease from childhood to adulthood: State of art and future directions. World Journal of Hepatology 2022; 14(6): 1087-1098 doi: 10.4254/wjh.v14.i6.1087
|
| 8 |
Marina Jara Vidal, Javier Torres Hernández, Marta Gallach Martínez, Andrés Ruíz de Assín Valverde, Laura Navarro Casado, Pedro J. Pinés Corrales. Prevalence of liver fibrosis index-4 (FIB-4) positive results in patients with diabetes. Medicina Clínica (English Edition) 2025; 165(2): 106981 doi: 10.1016/j.medcle.2025.106981
|
| 9 |
Weiwei He, Caoxin Huang, Liying Wang, Weijuan Su, Shunhua Wang, Peiying Huang, Xiaofang Zhang, Yinxiang Huang, Yan Zhao, Mingzhu Lin, Xiulin Shi, Xuejun Li. The correlation between triiodothyronine and the severity of liver fibrosis. BMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01228-8
|
| 10 |
Sharon Olabisoye Oladipupo, Emmanuel Henry Ezenabor, Adebola Busola Ojo, Akingbolabo Daniel Ogunlakin, Oluwafemi Adeleke Ojo. Interplay of the pathophysiological mechanisms of non-alcoholic fatty liver disease, diabetes mellitus, and inflammation: A growing threat to public health. Obesity Medicine 2025; 55: 100613 doi: 10.1016/j.obmed.2025.100613
|
| 11 |
Charilila-Loukia Ververeli, Yannis Dimitroglou, Stergios Soulaidopoulos, Evangelos Cholongitas, Constantina Aggeli, Konstantinos Tsioufis, Dimitris Tousoulis. Cardiac Remodeling and Arrhythmic Burden in Pre-Transplant Cirrhotic Patients: Pathophysiological Mechanisms and Management Strategies. Biomedicines 2025; 13(4): 812 doi: 10.3390/biomedicines13040812
|
| 12 |
Marina Jara Vidal, Javier Torres Hernández, Marta Gallach Martínez, Andrés Ruíz de Assín Valverde, Laura Navarro Casado, Pedro J. Pinés Corrales. Prevalence of liver fibrosis index-4 (FIB-4) positive results in patients with diabetes. Medicina Clínica 2025; 165(2): 106981 doi: 10.1016/j.medcli.2025.106981
|
| 13 |
Ghazala S Virk, Jaahnavi Vajje, Nausheen K Virk, Raam Mannam, Wajeeh Rehman, Naglaa G Ghobriel , Irfan-ud-din Mian, Muhammad Usama. Comparison of Outcomes Between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease: A Meta-Analysis. Cureus 2023; doi: 10.7759/cureus.44413
|